Scoping review outlines management of neutropenia in anticancer treatments, highlighting pathophysiology and treatment discontinuation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Antherieu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: